Tempest Therapeutics Inc Capital Reinvestment Ratio

Latest as of June 2021: 0.55x

Tempest Therapeutics Inc capital reinvestment ratio. Tempest Therapeutics Inc (TPST) has a Capital Reinvestment Ratio of 0.55x as of June 2021, meaning it reinvests 1% of its operating cash flow ($127.00K) in capital expenditures ($70.00K). Check TPST capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.55x

Capex / Operating Cash Flow

Operating Cash Flow

$127.00K

USD

Capital Expenditures

$70.00K

USD

Data as of

Jun 2021

Most recent filing

Tempest Therapeutics Inc Capital Reinvestment Ratio by Year (None–None)

Tempest Therapeutics Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Tempest Therapeutics Inc cash conversion from operations.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow